ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.16
0.45%
US Tech 100
20,877.20
1.72%
S&P 500
5,996.66
1.00%
US Dollar vs CAD
1.44195
0.82%
Bitcoin
102,371.83
0.34%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Italy
  5. BIT

  6. Philogen Spa (PHIL) Share Price

Philogen Spa

Philogen Spa (PHIL)

Pacific Horizon Investment Trust PLC
Pacific Horizon Investment Trust PLC
Pacific Horizon Investment Trust PLC
PHI Group Inc (PK)
18.75
0.10
(0.54%)
Closed January 20 10:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
18.75
Bid
17.70
Ask
18.75
Volume
1,108
18.40 Day's Range 18.65
16.30 52 Week Range 21.90
Market Cap
757.455M
Previous Close
18.65
Open
18.40
Last Trade
21
@
18.75
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
4,918
Shares Outstanding
40,397,605
Dividend Yield
-
PE Ratio
0.00
Earnings Per Share (EPS)
-
Revenue
25.12M
Net Profit
-6.16M

About Philogen Spa

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Website
www.philogen.com
Headquarters
Siena, Siena, Ita
Founded
-
Philogen Spa is listed in the Pharmaceutical Preparations sector of the Italian Stock Exchange with ticker PHIL. The last closing price for Philogen was 18.65 €. Over the last year, Philogen shares have traded in a share price range of 16.30 € to 21.90 €.

Philogen currently has 40,397,605 shares outstanding. The market capitalization of Philogen is 753.42 € million.

Ask ADVFN Intelligence (AI)

PHIL Latest News

More News

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue Sarcoma

Philogen provides update on pre-planned interim analysis of the Phase III FIBROSARC trial investigating Onfekafusp alfa (L19TNF) in patients with first-line advanced or metastatic Soft Tissue...

February 20 2024
GlobeNewswire Inc.

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities

Philogen S.p.A. announces receipt of the Good Manufacturing Practice Certificate for its new Production facility in Rosia (Siena, Italy) by Competent Authorities SIENA, Italy, Dec. 05, 2023...

December 05 2023
GlobeNewswire Inc.

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors

Philochem and Blue Earth Diagnostics Announce First Three Patients Imaged in Phase 1 Clinical Trial of 68Ga-OncoFAP (68Ga-OncoFAP-DOTAGA) for Diagnostic Imaging in Solid Tumors Novel...

December 04 2023
GlobeNewswire Inc.

Nidlegy™ Phase III PIVOTAL trial meets the study’s primary objective demonstrating statistically significant and clinically meaningful improvement in Recurrence-Free Survival for patients with locally advanced fully resectable melanoma

Intratumoral Nidlegy™ followed by surgery significantly improved the Recurrence-Free Survival compared to surgery alone PIVOTAL (NCT02938299) is the first and so far only Phase III trial...

October 16 2023
GlobeNewswire Inc.

Philogen Announces Clinical Trial Collaboration with MSD

Philogen Announces Clinical Trial Collaboration with MSD The Phase II clinical trial investigates Philogen's immunocytokines (i) L19IL2 (ii) L19TNF, and (iii) Nidlegy™ in combination with...

June 01 2023
GlobeNewswire Inc.

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand

Sun Pharma and Philogen enter into an Exclusive Distribution, License, and Supply Agreement for Commercializing specialty product, NIDLEGY™ in Europe, Australia and New Zealand Mumbai...

May 30 2023
GlobeNewswire Inc.

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich

Philogen Publishes New Data on a Fibromun-based treatment combination in Science Translational Medicine in collaboration with the University Hospital Zürich Philogen Publishes New Data on a...

May 25 2023
GlobeNewswire Inc.

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology

Philogen Announces Publication of a New Study in Collaboration with Google focused on Machine Learning models applied to DNA-Encoded Chemical Library Technology Philogen Announces Publication...

March 28 2023
GlobeNewswire Inc.

Philogen Provides Corporate Update

Philogen Provides Corporate Update Philogen Provides Corporate Update Nidlegy™ and Fibromun pivotal clinical trials on track Fibromun shows potent activity in last-line glioblastoma in...

December 01 2022
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.21.078167115918.5518.918.35613218.56542175DE
4-0.15-0.79365079365118.919.5518.35426618.83228924DE
12-1.95-9.4202898550720.720.718.05491819.18158431DE
26-2.25-10.71428571432121.918.05630819.92600016DE
520.150.80645161290318.621.916.3855519.10581607DE
1564.2929.668049792514.4621.913853216.93776531DE
2601.7510.29411764711721.912.61202616.03295556DE

PHIL - Frequently Asked Questions (FAQ)

What is the current Philogen share price?
The current share price of Philogen is 18.75 €
How many Philogen shares are in issue?
Philogen has 40,397,605 shares in issue
What is the market cap of Philogen?
The market capitalisation of Philogen is EUR 753.42M
What is the 1 year trading range for Philogen share price?
Philogen has traded in the range of 16.30 € to 21.90 € during the past year
What is the reporting currency for Philogen?
Philogen reports financial results in EUR
What is the latest annual turnover for Philogen?
The latest annual turnover of Philogen is EUR 25.12M
What is the latest annual profit for Philogen?
The latest annual profit of Philogen is EUR -6.16M
What is the registered address of Philogen?
The registered address for Philogen is PIAZZA LA LIZZA, 7, SIENA, SIENA, 53100
What is the Philogen website address?
The website address for Philogen is www.philogen.com
Which industry sector does Philogen operate in?
Philogen operates in the PHARMACEUTICAL PREPARATIONS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WSMN26Simone SpA
0.0699 €
(33.14%)
61k
BIROEstrima Spa
0.366 €
(24.49%)
486k
NTWNetweek SpA
0.0086 €
(22.86%)
2.54M
BESBestbe Holding
0.473 €
(17.08%)
201.24k
XHSXenia Hotellerie Solution SpA Societa Benefit
2.90 €
(16.94%)
38k
U24AXAUCapital24 Spa
0.0004 €
(-83.33%)
805.6k
WINC26Innovatec SpA
0.098 €
(-17.30%)
89.61k
1VOLVBVolvo AB
21.07 €
(-15.72%)
20
1WBAWalgreens Boots Alliance Inc
10.88 €
(-13.65%)
430
EPHEPH SpA
0.035 €
(-12.50%)
198.01k
TITTelecom Italia SpA
0.262 €
(-0.23%)
381.11M
TITRTelecom Italia
0.3078 €
(-0.48%)
41.76M
SPMSaipem Spa
2.53 €
(-1.02%)
24.63M
ENELEnel Spa
6.796 €
(-2.09%)
22.07M
ISPIntesa Sanpaolo Spa
4.177 €
(0.80%)
17.84M

Discussion

View Full Feed
arizona1 arizona1 4 minutes ago
I hardly notice any ads, but I’m so rarely on there, I’m probably not worth their time.
3331 3331 5 minutes ago
BIEL 911 NEWS!
boston745 boston745 6 minutes ago
I do not know why, but there does not seem to be studies connecting immune responses/disease connected to the combination of EMFs like indicated in this first study and the next article listing immune disorders associated with metal implants. In reality its likely that metal ions/metal implants them
SINT
Roman516 Roman516 7 minutes ago
NoGro, guess you never understood the trial since the PROTOCOL -- PFS was the PRIMARY endpoint was worthless based on the OS results.
That is ok since your comments have zero value compared to the 100's of oncologists, cancer centers, universities, professional scientists and a host of others
NWBO
fuagf fuagf 10 minutes ago
Update 8 min - Why some are attracted to assholes like Trump. Couple of interesting videos featuring political
scientist Brian Klass -- https://www.google.com/search?client=firefox-b-d&q=brian+klaas

This is the reason some people are drawn to “strongmen” leaders

Zorax Zorax 12 minutes ago
Yep, it's your thing anyways... but this is part of what I'm talking about.

We'll still receive activity from apps and websites. It may be used for measurement purposes and to make improvements to our ads systems, but it will be disconnected from your account.
You'll still see
A51Rob A51Rob 12 minutes ago
Looking for news this week maybe VGTel team will be announced or maybe more information on those projects that VGTel mentioned.
VGTL
BadCuda BadCuda 12 minutes ago
Elon mentioning XRP https://www.facebook.com/share/r/1A9xHZw3V9/?mibextid=wwXIfr
XRPUSD
Dabeav Dabeav 14 minutes ago
Take the money you got vested out, then play w house money like me , I have thought about it. Thank you for asking.
I hope it goes to a thousand per share but it’s been the same o sh$t yr after yr.
T
BDEZ BDEZ 14 minutes ago
JD Vance was born in the poorest part of the country to a drug-addicted single mother

Now he is the VP of the USA

https://x.com/EndWokeness/status/1881404382610444468
StayHumble StayHumble 15 minutes ago
wow!💹179Million+ BUYS💹Lots of Xperts Here💹💹💹 https://ih.advfn.com/stock-market/USOTC/humbl-pk-HMBL/trades
https://cdn.vox-cdn.com/uploads/chorus_asset/file/8687957/tenor.gif
HMBL
Bigfootbud Bigfootbud 15 minutes ago
I created a fun thing back in 2020... OFFICIAL PET TRUMP - Remember THE PET ROCK??? YES it's mine... ♥ http://officialpettrump.com/
TRAPPER JIM TRAPPER JIM 15 minutes ago
MY OHIO STATE BUCKEYES ARE NATIONAL CHAMPIONS. WOOHOO WE WON THE GAME TONIGHT 
Bigfootbud Bigfootbud 16 minutes ago
I created a fun thing back in 2020... OFFICIAL PET TRUMP - Remember THE PET ROCK??? YES it's mine... ♥ http://officialpettrump.com/
CTS CTS 18 minutes ago
Navy contract news posted by CEO on LinkedIn. Why wouldn’t they PR this and simply post on LinkedIn!? At least put it under the News section on the website LOL.

😭
BSTK
HyGro HyGro 19 minutes ago
Guess you never read the trial PROTOCOL -- PFS was the PRIMARY endpoint.
NWBO
Bigfootbud Bigfootbud 19 minutes ago
I created a fun thing back in 2020... OFFICIAL PET TRUMP - Remember THE PET ROCK??? YES it's mine... ♥ http://officialpettrump.com/
Bigfootbud Bigfootbud 20 minutes ago
I created a fun thing back in 2020... Remember THE PET ROCK??? YES it's mine... ♥ http://officialpettrump.com/
BDEZ BDEZ 20 minutes ago
Jake Lang was just assaulted by a prison guard and then thrown in a cell
Fdc4 Fdc4 20 minutes ago
Because it is an empty shell with nothing in it. Only thing left is the ego of the bags against bashers’ …. Now, time will tell on what YBYRA will do with us
HMBL
Bigfootbud Bigfootbud 22 minutes ago
Love!!!
Maxthedog Maxthedog 22 minutes ago
We had positive news for the past 2 months only to retrace and go further down. What make this news any different, gap up in the morning and be positive for a few days, then go down and hit .45 before earnings.
I wonder if the courts can reach a verdict shortly after 1/22 hearing.
ELTP
NomadGolem39 NomadGolem39 23 minutes ago
littlejohn Textbook bull flag. Points to a new leg higher well above $50.
SMCI

Your Recent History

BIT
PHIL
Philogen
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads